{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T15:36:31Z","timestamp":1777304191855,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key R&D Project of Sichuan Provincial Department of Science and Technology","award":["2023YFS0089"],"award-info":[{"award-number":["2023YFS0089"]}]},{"name":"Key Project of Sichuan Provincial Natural Science Foundation","award":["2022NSFSC0051"],"award-info":[{"award-number":["2022NSFSC0051"]}]},{"name":"Clinical Scientist Program of Sichuan Cancer Hospital","award":["YB2022003"],"award-info":[{"award-number":["YB2022003"]}]},{"name":"Chengdu Science and Technology Innovation R&D Project","award":["2021YF0501659SN"],"award-info":[{"award-number":["2021YF0501659SN"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-13581-7","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T13:31:38Z","timestamp":1738243898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Infiltration and subtype analysis of CD3\u2009+\u2009CD20\u2009+\u2009T cells in lung cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Liping","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maotao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weidong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"issue":"6","key":"13581_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"13581_CR2","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1038\/s41467-020-19973-6","volume":"11","author":"M Zhang","year":"2020","unstructured":"Zhang M, Yang W, Wang P, et al. CCL7 recruits cDC1 to promote antitumor immunity and facilitate checkpoint immunotherapy to non-small cell lung cancer. Nat Commun. 2020;11(1):6119. https:\/\/doi.org\/10.1038\/s41467-020-19973-6.","journal-title":"Nat Commun"},{"issue":"5","key":"13581_CR3","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.21037\/tlcr-23-739","volume":"13","author":"Y Lin","year":"2024","unstructured":"Lin Y, Wang Y, Xue Q, et al. GPRC5A is a potential prognostic biomarker and correlates with immune cell infiltration in non-small cell lung cancer. Transl Lung Cancer Res. 2024;13(5):1010\u201331. https:\/\/doi.org\/10.21037\/tlcr-23-739.","journal-title":"Transl Lung Cancer Res"},{"issue":"9","key":"13581_CR4","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.3390\/cancers","volume":"14","author":"R Guennoun","year":"2022","unstructured":"Guennoun R, Hojanazarova J, Trerice KE, et al. Thymic stromal lymphopoietin induction suppresses lung cancer development. Cancers (Basel). 2022;14(9):2173. https:\/\/doi.org\/10.3390\/cancers14092173.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"13581_CR5","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3390\/cells11030320","volume":"11","author":"S Tang","year":"2022","unstructured":"Tang S, Qin C, Hu H, et al. Immune checkpoint inhibitors in non-small cell lung cancer: progress, challenges, and prospects. Cells. 2022;11(3):320. https:\/\/doi.org\/10.3390\/cells11030320.","journal-title":"Cells"},{"key":"13581_CR6","doi-asserted-by":"publisher","first-page":"541330","DOI":"10.3389\/fonc.2020.541330","volume":"10","author":"X Qi","year":"2020","unstructured":"Qi X, Qi C, Qin B, et al. Immune-stromal score signature: novel prognostic tool of the tumor microenvironment in lung adenocarcinoma. Front Oncol. 2020;10:541330. https:\/\/doi.org\/10.3389\/fonc.2020.541330.","journal-title":"Front Oncol"},{"issue":"3","key":"13581_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.humimm.2019.01.001","volume":"80","author":"Q Chen","year":"2019","unstructured":"Chen Q, Yuan S, Sun H, Peng L. CD3\u2009+\u2009CD20\u2009+\u2009T cells and their roles in human diseases. Hum Immunol. 2019;80(3):191\u20134. https:\/\/doi.org\/10.1016\/j.humimm.2019.01.001.","journal-title":"Hum Immunol"},{"issue":"4","key":"13581_CR8","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.4049\/jimmunol.1600089","volume":"197","author":"E Schuh","year":"2016","unstructured":"Schuh E, Berer K, Mulazzani M, et al. Features of human CD3\u2009+\u2009CD20\u2009+\u2009T cells. J Immunol. 2016;197(4):1111\u20137. https:\/\/doi.org\/10.4049\/jimmunol.1600089.","journal-title":"J Immunol"},{"issue":"10\u201311","key":"13581_CR9","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00011-022-01622-x","volume":"71","author":"AYS Lee","year":"2022","unstructured":"Lee AYS. CD20\u2009+\u2009T cells: an emerging T cell subset in human pathology. Inflamm Res. 2022;71(10\u201311):1181\u20139. https:\/\/doi.org\/10.1007\/s00011-022-01622-x.","journal-title":"Inflamm Res"},{"issue":"6","key":"13581_CR10","doi-asserted-by":"publisher","first-page":"e0176022","DOI":"10.1128\/jvi.01760-22","volume":"97","author":"S Samer","year":"2023","unstructured":"Samer S, Chowdhury A, Wiche Salinas TR, et al. Lymph-node-based CD3\u2009+\u2009CD20\u2009+\u2009cells emerge from membrane exchange between T follicular helper cells and b cells and increase their frequency following simian immunodeficiency virus infection. J Virol. 2023;97(6):e0176022. https:\/\/doi.org\/10.1128\/jvi.01760-22.","journal-title":"J Virol"},{"key":"13581_CR11","doi-asserted-by":"publisher","first-page":"577564","DOI":"10.1016\/j.jneuroim.2021.577564","volume":"355","author":"JK Lee","year":"2021","unstructured":"Lee JK, Kwon S, Han JH, et al. Increased proportion of CD20\u2009+\u2009T cells after rituximab treatment in patient with neuromyelitis optica later diagnosed with lung B-cell lymphoma: a case report. J Neuroimmunol. 2021;355:577564. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577564.","journal-title":"J Neuroimmunol"},{"issue":"4","key":"13581_CR12","doi-asserted-by":"publisher","first-page":"e999536","DOI":"10.1080\/2162402X.2014.999536","volume":"4","author":"M de Bruyn","year":"2015","unstructured":"de Bruyn M, Wiersma VR, Wouters MC, et al. CD20\u2009+\u2009T cells have a predominantly Tc1 effector memory phenotype and are expanded in the ascites of patients with ovarian cancer. Oncoimmunology. 2015;4(4):e999536. https:\/\/doi.org\/10.1080\/2162402X.2014.999536.","journal-title":"Oncoimmunology"},{"issue":"1","key":"13581_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cell.2020.08.025","volume":"183","author":"N Kaneko","year":"2020","unstructured":"Kaneko N, Kuo HH, Boucau J, et al. Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal centers in COVID-19. Cell. 2020;183(1):143\u2013e15713. https:\/\/doi.org\/10.1016\/j.cell.2020.08.025.","journal-title":"Cell"},{"issue":"7551","key":"13581_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature14175","volume":"521","author":"T Kopp","year":"2015","unstructured":"Kopp T, Riedl E, Bangert C, et al. Clinical improvement in psoriasis with specific targeting of interleukin-23. Nature. 2015;521(7551):222\u20136. https:\/\/doi.org\/10.1038\/nature14175.","journal-title":"Nature"},{"issue":"3","key":"13581_CR15","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jhep.2021.10.030","volume":"76","author":"GY Ding","year":"2022","unstructured":"Ding GY, Ma JQ, Yun JP, et al. Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma. J Hepatol. 2022;76(3):608\u201318. https:\/\/doi.org\/10.1016\/j.jhep.2021.10.030.","journal-title":"J Hepatol"},{"issue":"9","key":"13581_CR16","doi-asserted-by":"publisher","first-page":"e0256907","DOI":"10.1371\/journal.pone.0256907","volume":"16","author":"P Barmpoutis","year":"2021","unstructured":"Barmpoutis P, Di Capite M, Kayhanian H, et al. Tertiary lymphoid structures (TLS) identification and density assessment on H&E-stained digital slides of lung cancer. PLoS ONE. 2021;16(9):e0256907. https:\/\/doi.org\/10.1371\/journal.pone.0256907","journal-title":"PLoS ONE"},{"issue":"8","key":"13581_CR17","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41581-023-00706-z","volume":"19","author":"Y Sato","year":"2023","unstructured":"Sato Y, Silina K, van den Broek M, et al. The roles of tertiary lymphoid structures in chronic diseases. Nat Rev Nephrol. 2023;19(8):525\u201337. https:\/\/doi.org\/10.1038\/s41581-023-00706-z.","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"13581_CR18","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.ccell.2024.07.006","volume":"42","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Liu G, Zeng Q, et al. CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis. Cancer Cell. 2024;42(8):1370\u2013e13859. https:\/\/doi.org\/10.1016\/j.ccell.2024.07.006.","journal-title":"Cancer Cell"},{"key":"13581_CR19","doi-asserted-by":"publisher","first-page":"816005","DOI":"10.3389\/fimmu.2022","volume":"13","author":"Z Wu","year":"2022","unstructured":"Wu Z, Zheng Y, Sheng J, et al. CD3\u2009+\u2009CD4-CD8- (Double-Negative) T cells in inflammation, immune disorders and cancer. Front Immunol. 2022;13:816005. https:\/\/doi.org\/10.3389\/fimmu.2022.","journal-title":"Front Immunol"},{"issue":"2","key":"13581_CR20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nri3384","volume":"13","author":"P Vantourout","year":"2013","unstructured":"Vantourout P, Hayday A. Six-of-the-best: unique contributions of \u03b3\u03b4 T cells to immunology. Nat Rev Immunol. 2013;13(2):88\u2013100. https:\/\/doi.org\/10.1038\/nri3384.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"13581_CR21","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/mi.2015.91","volume":"9","author":"K Neyt","year":"2016","unstructured":"Neyt K, GeurtsvanKessel CH, Lambrecht BN. Double-negative T resident memory cells of the lung react to influenza virus infection via CD11c(hi) dendritic cells. Mucosal Immunol. 2016;9(4):999\u20131014. https:\/\/doi.org\/10.1038\/mi.2015.91.","journal-title":"Mucosal Immunol"},{"issue":"4","key":"13581_CR22","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1681\/ASN.2014121214","volume":"27","author":"MN Martina","year":"2016","unstructured":"Martina MN, Noel S, Saxena A, et al. Double-negative \u03b1\u03b2 T cells are early responders to aki and are found in human kidney. J Am Soc Nephrol. 2016;27(4):1113\u201323. https:\/\/doi.org\/10.1681\/ASN.2014121214.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"13581_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13046-019-1126-y","volume":"38","author":"L Fang","year":"2019","unstructured":"Fang L, Ly D, Wang SS, et al. Targeting late-stage non-small cell lung cancer with a combination of DNT cellular therapy and PD-1 checkpoint blockade. J Exp Clin Cancer Res. 2019;38(1):123. https:\/\/doi.org\/10.1186\/s13046-019-1126-y.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1\u20133","key":"13581_CR24","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s12026-009-8144-3","volume":"47","author":"AR Hamad","year":"2010","unstructured":"Hamad AR. Analysis of gene profile, steady state proliferation and apoptosis of double-negative T cells in the periphery and gut epithelium provides new insights into the biological functions of the Fas pathway. Immunol Res. 2010;47(1\u20133):134\u201342. https:\/\/doi.org\/10.1007\/s12026-009-8144-3.","journal-title":"Immunol Res"},{"issue":"1","key":"13581_CR25","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1158\/0008-5472.CAN-13-1672","volume":"74","author":"V Vallacchi","year":"2014","unstructured":"Vallacchi V, Vergani E, Camisaschi C, et al. Transcriptional profiling of melanoma sentinel nodes identify patients with poor outcome and reveal an association of CD30(+) T lymphocytes with progression. Cancer Res. 2014;74(1):130\u201340. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-1672.","journal-title":"Cancer Res"},{"key":"13581_CR26","doi-asserted-by":"publisher","first-page":"104260","DOI":"10.1016\/j.cellimm.2020.104260","volume":"360","author":"TW Mudd Jr","year":"2021","unstructured":"Mudd TW Jr, Lu C, Klement JD, Liu K. MS4A1 expression and function in T cells in the colorectal cancer tumor microenvironment. Cell Immunol. 2021;360:104260. https:\/\/doi.org\/10.1016\/j.cellimm.2020.104260.","journal-title":"Cell Immunol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13581-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13581-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13581-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T13:31:48Z","timestamp":1738243908000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13581-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13581"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13581-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"17 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study, conducted in accordance with the Declaration of Helsinki, received approval from the Medical Ethics Committee of Sichuan Cancer Hospital (SCCHEC-02-2021-064). As this is a retrospective study that does not involve any intervention in the treatment of patients, nor increase the treatment cost of patients, and does not study any identifiable individual characteristics of patients, SCCHEC is authorized to waive the need for filling in the informed consent form. The Ethics Committee of Meishan Cancer Hospital also recognized and endorsed this approval number, allowing for the collection of patient samples and data at both institutions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"179"}}